Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Europe gives green light to new Novartis, Alexion drugs

[Reuters] – New drugs from Novartis and Alexion won a green light from European regulators on Friday, delivering a boost to both drugmakers and offering new treatment options for cancer and rare diseases. . . . → Read More: Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Europe gives green light to new Novartis, Alexion drugs Similar Articles: Market Update (NASDAQ:AMGN): Amgen cholesterol drug could get EU green light this week Company Update (NYSE:BMY): EU regulators warn against combining hep C drugs with amiodarone Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals to Report First Quarter 2015 Results on Thursday, April 23, 2015